Hemispherx Biopharma (HEB)
Hemispherx Biopharma Price / Tangible Book Value: 1.023
View HEB Price / Tangible Book Value with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
HEB Price / Tangible Book Value Rankings
| Overall | 76th percentile | 893 of 3768 |
| Sector | 90th percentile | 38 of 419 in Healthcare |
| Industry | 92nd percentile | 11 of 140 in Biotechnology |
HEB Price / Tangible Book Value Range, Past 5 Years
| Minimum | 0.7127 | Dec 2011 |
| Maximum | 6.247 | Jun 2009 |
| Average | 2.617 |
About Price to Tangible Book Value
Click the "Learn More" link below to see how YCharts calculates Price to Tangible Book Value.
The Price to Tangible Book Value ratio (PTBV) expresses share price as a proportion of the company's tangible book value reported on the company's balance sheet. Tangible book value is calculated by subtracting intangible assets (intellectual property, patents, goodwill etc.) from the company's book value.
Theoretically, PTBV represents the amount of money that shareholders would receive for each share owned if the company were to liquidate its operations. A higher PTBV indicates a higher level of risk due to increased potential for share price losses.
Learn More
You may also be interested in these HEB related companies
HEB News
$HEB maybe Carter can put Ampligen in e-cigarettes now that it's 2012 since he already explored putting it in real cigarettes in the 1980's
about 22 days ago by HankHill
about 22 days ago by HankHill
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2012
May 07, 4:35PM GlobeNewswire
May 07, 4:35PM GlobeNewswire
$heb ever hold a stock so you could laugh at it every day ? i have
about 40 days ago by roadkingtrdr
about 40 days ago by roadkingtrdr
Hemispherx Biopharma, Inc. to Host 2011 Year End Conference Call on Thursday, March 22, 2012
Mar 20, 8:30AM GlobeNewswire
Mar 20, 8:30AM GlobeNewswire
$HEB Cross over coming also a Triple top breakout at stockcharts.com on the P&F.
about 71 days ago by rtk
about 71 days ago by rtk
Hemispherx Publishes Data on the Bioactivity of Ampligen(R) in Chronic Fatigue Syndrome ("CFS")
Mar 19, 8:30AM GlobeNewswire
Mar 19, 8:30AM GlobeNewswire
$HEB , I am early but bot it this morning. loking for a nice pop
about 116 days ago by 3DTRADINGTRADER
about 116 days ago by 3DTRADINGTRADER
Hemispherx Biopharma Receives U.S. Patent Office Notification of Two New Patents Granted for Alferon(R) LDO
Jan 17, 8:30AM GlobeNewswire
Jan 17, 8:30AM GlobeNewswire
Hemispherx Biopharma (HEB) Recieves FDA Extension for NDA for Treatment of Chronic Fatigue Syndrome
Jan 11, 8:35AM Street Insider
Jan 11, 8:35AM Street Insider
$HEB shares up 14% following extension to modify NDA for treatment of CFS
about 139 days ago by Street_Insider
about 139 days ago by Street_Insider
Hemispherx Biopharma (HEB) Gets Extension from FDA for CFS NDA Modification
Jan 11, 8:31AM Street Insider
Jan 11, 8:31AM Street Insider
FDA Grants $HEB Extension in Its Pending New Drug Application for the Treatment of Chronic Fatigue
about 139 days ago by Benzinga
about 139 days ago by Benzinga
Hemispherx Biopharma Announces Further Adjournment on Proposal Number 4 From the 2011 Annual Meeting of Stockholders
Nov 09, 4:13PM GlobeNewswire
Nov 09, 4:13PM GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended September 30, 2011
Nov 09, 12:26PM GlobeNewswire
Nov 09, 12:26PM GlobeNewswire
Hemispherx Biopharma, Inc. to Host Conference Call on Chronic Fatigue Syndrome Progress Thursday, October 27, 2011
Oct 24, 10:22AM GlobeNewswire
Oct 24, 10:22AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HEB | 0.28 | +0.01 | +3.70% | 36.67M |
| ISIL | 10.84 | +0.40 | +3.83% | 1.322B |
| ISIG | 1.90 | +0.01 | +0.53% | 25.70M |
| ISI | 60.05 | -0.10 | -0.17% | |
| ISH | 18.35 | +0.25 | +1.38% | 130.68M |
| ISCA | 23.99 | +0.54 | +2.30% | 1.085B |
| IPSU | 6.34 | -0.01 | -0.16% | 77.60M |
| IPS | 31.32 | +0.04 | +0.13% | |
| IPN | 22.70 | -0.20 | -0.87% | |
| IPK | 22.62 | +0.14 | +0.62% |
